FMTX insider filings
Forma Therapeutics Holdings, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-10-14. Screen FMTX transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for FMTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Forma Therapeutics Holdings, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2022-10-14 | 4 | Lesser Brian Andrew — SVP, Commercial Officer | Code (U): 10,000 · Code (U): 42,593 · Disposition to issuer (D): 32,987 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 46,756 (derivative) · Disposition to issuer (D): 46,756 (derivative) · +2 more | EDGAR |
| 2022-10-14 | 4 | Potts Jeannette — See Remarks | Code (U): 3,400 · Code (U): 43,958 · Disposition to issuer (D): 111,746 (derivative) · Disposition to issuer (D): 11,689 (derivative) · Disposition to issuer (D): 105,201 (derivative) · Disposition to issuer (D): 72,004 (derivative) · +2 more | EDGAR |
| 2022-10-14 | 4 | Frederick Wayne A.I. — Director | Code (U): 7,250 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative) | EDGAR |
| 2022-10-14 | 4 | Lee Frank D. — President and CEO, Director | Code (U): 201,436 · Disposition to issuer (D): 678,357 (derivative) · Disposition to issuer (D): 70,134 (derivative) · Disposition to issuer (D): 748,100 (derivative) · Disposition to issuer (D): 71,770 (derivative) · Disposition to issuer (D): 175,875 (derivative) · +1 more | EDGAR |
| 2022-10-14 | 4 | Melian Agustin — EVP, Research & Development | Code (U): 79,000 · Disposition to issuer (D): 118,000 (derivative) | EDGAR |
| 2022-10-14 | 4 | Shegog Todd — SVP, Chief Financial Officer | Code (U): 56,143 · Disposition to issuer (D): 153,528 (derivative) · Disposition to issuer (D): 11,689 (derivative) · Disposition to issuer (D): 116,890 (derivative) · Disposition to issuer (D): 70,134 (derivative) · Disposition to issuer (D): 50,250 (derivative) · +1 more | EDGAR |
| 2022-10-14 | 4 | MOLINA ARTURO MD — Director | Code (U): 10,000 · Disposition to issuer (D): 16,750 (derivative) · Disposition to issuer (D): 6,750 (derivative) | EDGAR |
| 2022-10-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Code (U): 7,250 · Code (U): 7,500,226 · Code (U): 1,511,425 · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative) | EDGAR |
| 2022-10-14 | 4 | Bishop John E — SVP, Chief Technology Officer | Code (U): 47,950 · Disposition to issuer (D): 67,000 (derivative) · Disposition to issuer (D): 38,930 (derivative) | EDGAR |
| 2022-10-14 | 4 | Fanucci Marsha — Director | Code (U): 52,532 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · +1 more | EDGAR |
| 2022-10-14 | 4 | CLACKSON TIMOTHY P — Director | Code (U): 23,590 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 9,351 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · +2 more | EDGAR |
| 2022-10-14 | 4 | WIGGANS THOMAS G — Director | Code (U): 7,250 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 8,375 (derivative) · Disposition to issuer (D): 6,750 (derivative) | EDGAR |
| 2022-10-14 | 4 | WIRTH PETER — Director | Code (U): 127,665 · Code (U): 7,250 · Disposition to issuer (D): 14,026 (derivative) · Disposition to issuer (D): 28,053 (derivative) · Disposition to issuer (D): 17,533 (derivative) · Disposition to issuer (D): 8,375 (derivative) · +1 more | EDGAR |
| 2022-07-12 | 4 | Melian Agustin — EVP, Research & Development | Grant/award (A): 79,000 @ $0 · Grant/award (A): 118,000 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Frederick Wayne A.I. — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Vickers Selwyn M MD — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | MOLINA ARTURO MD — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | Fanucci Marsha — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | CLACKSON TIMOTHY P — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | WIGGANS THOMAS G — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-06-09 | 4 | WIRTH PETER — Director | Grant/award (A): 4,500 @ $0 · Grant/award (A): 6,750 (derivative) @ $0 | EDGAR |
| 2022-04-14 | 4 | Kelly Patrick F. — SVP, Chief Medical Officer | Option exercise (M): 15,000 @ $5.05 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Lesser Brian Andrew — SVP, Commercial | Grant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Lee Frank D. — President and CEO, Director | Grant/award (A): 121,667 @ $0 · Grant/award (A): 182,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Kelly Patrick F. — SVP, Chief Medical Officer | Grant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Shegog Todd — SVP, Chief Financial Officer | Grant/award (A): 33,330 @ $0 · Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Potts Jeannette — See Remarks | Grant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | Bishop John E — SVP, Chief Technology Officer | Grant/award (A): 25,950 @ $0 · Grant/award (A): 38,930 (derivative) @ $0 | EDGAR |
| 2022-03-02 | 4 | COOK DAVID N — SVP, Chief Scientific Officer | Grant/award (A): 25,000 @ $0 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2022-02-25 | 4 | Lee Frank D. — President and CEO, Director | Sale (S): 17,981 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | Kelly Patrick F. — SVP, Chief Medical Officer | Sale (S): 5,245 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | Shegog Todd — SVP, Chief Financial Officer | Sale (S): 5,687 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | Lesser Brian Andrew — SVP, Commercial | Sale (S): 3,837 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | Wadlinger Mary E. — See Remarks | Sale (S): 4,684 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | Potts Jeannette — See Remarks | Sale (S): 4,672 @ $9.78 | EDGAR |
| 2022-02-25 | 4 | COOK DAVID N — SVP, Chief Scientific Officer | Sale (S): 3,531 @ $9.78 | EDGAR |
| 2022-01-13 | 4 | MOLINA ARTURO MD — Director | Grant/award (A): 5,500 @ $0 · Grant/award (A): 16,750 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Vickers Selwyn M MD — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Frederick Wayne A.I. — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Kolchinsky Peter — Director, 10% owner | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | Fanucci Marsha — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | CLACKSON TIMOTHY P — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | WIGGANS THOMAS G — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-21 | 4 | WIRTH PETER — Director | Grant/award (A): 2,750 @ $0 · Grant/award (A): 8,375 (derivative) @ $0 | EDGAR |
| 2021-06-15 | 4 | Bishop John E — Chief Technology Officer | Grant/award (A): 22,000 @ $0 · Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2021-04-05 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — 10% owner Kolchinsky Peter — 10% owner Shah Rajeev M. — 10% owner | Other (J): 542,018 @ $28.02 | EDGAR |
| 2021-03-02 | 4 | Shegog Todd — SVP, Chief Financial Officer | Grant/award (A): 16,500 @ $0 · Grant/award (A): 12,000 @ $0 · Grant/award (A): 50,250 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Lee Frank D. — President and CEO, Director | Grant/award (A): 57,750 @ $0 · Grant/award (A): 40,000 @ $0 · Grant/award (A): 175,875 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | Kelly Patrick F. — Chief Medical Officer | Grant/award (A): 16,500 @ $0 · Grant/award (A): 10,670 @ $0 · Grant/award (A): 50,250 (derivative) @ $0 | EDGAR |
| 2021-03-02 | 4 | COOK DAVID N — SVP, Chief Scientific Officer | Grant/award (A): 14,300 @ $0 · Grant/award (A): 5,700 @ $0 · Grant/award (A): 43,550 (derivative) @ $0 | EDGAR |
Recent 8-K events — Forma Therapeutics Holdings, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2022-10-14 | 8-K | 1.02 — Termination of a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.03 — Material Modification to Rights of Security Holders 5.01 — Changes in Control of Registrant 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-07-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2022-06-09 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2022-05-26 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-03-01 | 8-K | 2.02 — Results of Operations and Financial Condition 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-01-13 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2021-12-16 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FMTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs